Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study

Hans Christian Ring; Jonathan Thorsen; Brian Kirby; John R Ingram; Nana Aviaaja Lippert Rosenø; Nikolaj Holgersen; Valdemar W Nielsen; David Nikolai Thein Aagaard; Julia-Tatjana Maul; Jashin J Wu; Jacob P Thyssen; Alexander Egeberg; Simon F Thomsen

doi:10.1093/bjd/ljae042

Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study

Hans Christian Ring^*, Jonathan Thorsen, Brian Kirby, John R Ingram, Nana Aviaaja Lippert Rosenø, Nikolaj Holgersen, Valdemar W Nielsen, David Nikolai Thein Aagaard, Julia-Tatjana Maul, Jashin J Wu, Jacob P Thyssen, Alexander Egeberg, Simon F Thomsen

^*Corresponding author af dette arbejde

7 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	British Journal of Dermatology
Vol/bind	190
Udgave nummer	5
Sider (fra-til)	769-771
Antal sider	3
ISSN	0007-0963
DOI	https://doi.org/10.1093/bjd/ljae042
Status	Udgivet - 17 apr. 2024

Adgang til dokumentet

10.1093/bjd/ljae042

Andre filer og links

Link to publication in Scopus

Citationsformater

Ring, H. C., Thorsen, J., Kirby, B., Ingram, J. R., Rosenø, N. A. L., Holgersen, N., Nielsen, V. W., Thein Aagaard, D. N., Maul, J.-T., Wu, J. J., Thyssen, J. P., Egeberg, A., & Thomsen, S. F. (2024). Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study. British Journal of Dermatology, 190(5), 769-771. https://doi.org/10.1093/bjd/ljae042

Ring, HC, Thorsen, J, Kirby, B, Ingram, JR, Rosenø, NAL , Holgersen, N , Nielsen, VW, Thein Aagaard, DN, Maul, J-T, Wu, JJ, Thyssen, JP , Egeberg, A & Thomsen, SF 2024, 'Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study', British Journal of Dermatology, bind 190, nr. 5, s. 769-771. https://doi.org/10.1093/bjd/ljae042

@article{9d0cbdfe3fc3448db6ef90ef34c8011b,

title = "Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study",

keywords = "Humans, Adalimumab, Ustekinumab, Infliximab, Hidradenitis Suppurativa, Cohort Studies, Denmark, Antibodies, Monoclonal, Humanized",

author = "Ring, \{Hans Christian\} and Jonathan Thorsen and Brian Kirby and Ingram, \{John R\} and Rosen{\o}, \{Nana Aviaaja Lippert\} and Nikolaj Holgersen and Nielsen, \{Valdemar W\} and \{Thein Aagaard\}, \{David Nikolai\} and Julia-Tatjana Maul and Wu, \{Jashin J\} and Thyssen, \{Jacob P\} and Alexander Egeberg and Thomsen, \{Simon F\}",

year = "2024",

month = apr,

day = "17",

doi = "10.1093/bjd/ljae042",

language = "English",

volume = "190",

pages = "769--771",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa

T2 - a Danish nationwide cohort study

AU - Ring, Hans Christian

AU - Thorsen, Jonathan

AU - Kirby, Brian

AU - Ingram, John R

AU - Rosenø, Nana Aviaaja Lippert

AU - Holgersen, Nikolaj

AU - Nielsen, Valdemar W

AU - Thein Aagaard, David Nikolai

AU - Maul, Julia-Tatjana

AU - Wu, Jashin J

AU - Thyssen, Jacob P

AU - Egeberg, Alexander

AU - Thomsen, Simon F

PY - 2024/4/17

Y1 - 2024/4/17

KW - Humans

KW - Adalimumab

KW - Ustekinumab

KW - Infliximab

KW - Hidradenitis Suppurativa

KW - Cohort Studies

KW - Denmark

KW - Antibodies, Monoclonal, Humanized

UR - https://www.scopus.com/pages/publications/85190902734

U2 - 10.1093/bjd/ljae042

DO - 10.1093/bjd/ljae042

M3 - Letter

C2 - 38305415

SN - 0007-0963

VL - 190

SP - 769

EP - 771

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 5

ER -